HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Ichinose Selected Research

DCM-Dex-CDDP

1/2000Antitumor activity of dextran derivatives immobilizing platinum complex (II).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Ichinose Research Topics

Disease

5Rheumatoid Arthritis
01/2022 - 01/2018
3Neoplasms (Cancer)
07/2000 - 01/2000
2Dermatomyositis (Dermatopolymyositis)
01/2021 - 01/2009
2Lupus Nephritis
04/2019 - 07/2018
2Hepatocellular Carcinoma (Hepatoma)
07/2000 - 01/2000
1Rheumatic Diseases (Rheumatism)
01/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1Vasculitis (Vasculitides)
07/2020
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
07/2020
1Microscopic Polyangiitis
07/2020
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
07/2020
1Necrosis
01/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2018
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
07/2018
1Familial Mediterranean Fever (Periodic Disease)
01/2018
1Myositis (Idiopathic Inflammatory Myopathies)
01/2009
1Peritoneal Fibrosis
02/2007
1Diabetic Nephropathies (Diabetic Nephropathy)
02/2007
1Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
07/2001
1Dehydration (Water Stress)
02/2001
1Lung Neoplasms (Lung Cancer)
07/2000
1Colonic Neoplasms (Colon Cancer)
07/2000

Drug/Important Bio-Agent (IBA)

2Antirheumatic Agents (DMARD)IBA
01/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2021
2Abatacept (Orencia)FDA Link
01/2021 - 01/2020
2AntibodiesIBA
01/2021 - 01/2009
2Peptides (Polypeptides)IBA
01/2009 - 02/2007
2Polysaccharides (Glycans)IBA
07/2000 - 01/2000
2Liposomes (Liposome)IBA
07/2000 - 01/2000
1Janus KinasesIBA
01/2022
1Janus Kinase InhibitorsIBA
01/2022
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2021
1AntigensIBA
01/2021
1Interleukin-15 (Interleukin 15)IBA
01/2021
1Complement System Proteins (Complement)IBA
07/2020
1Complement C3b (C3bi)IBA
07/2020
1Fibrinogen (Factor I)FDA Link
07/2020
1ProperdinIBA
07/2020
1Complement Factor B (Factor B)IBA
07/2020
1Complement Factor D (Factor D)IBA
07/2020
1Complement Factor H (Factor H)IBA
07/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
07/2020
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
07/2020
1Anti-Citrullinated Protein AntibodiesIBA
01/2020
1Tumor Necrosis Factor InhibitorsIBA
01/2020
1Tacrolimus (Prograf)FDA LinkGeneric
07/2018
1Prednisolone (Predate)FDA LinkGeneric
07/2018
1CytokinesIBA
01/2018
1Transfer RNA (tRNA)IBA
01/2009
1Ligases (Synthetase)IBA
01/2009
1AutoantibodiesIBA
01/2009
1chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
02/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2007
1EndostatinsIBA
02/2007
1Collagen Type XVIII (Type XVIII Collagen)IBA
02/2007
1peptide AIBA
02/2007
1Therapeutic UsesIBA
02/2007
1Etoposide (VP 16)FDA LinkGeneric
07/2001
1Melanins (Melanin)IBA
02/2001
1CarbonIBA
02/2001
1Galactose (Galactopyranose)FDA LinkGeneric
07/2000
1Asialoglycoprotein ReceptorIBA
07/2000
1LactoseFDA LinkGeneric
07/2000
1CholesterolIBA
07/2000
1pullulanIBA
07/2000
1DCM-Dex-CDDPIBA
01/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2000 - 01/2000
1Aftercare (After-Treatment)
01/2021
1Therapeutics
04/2019
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
02/2007
1Intraperitoneal Injections
02/2007